Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Share Capital (Tables)

v3.22.2.2
Share Capital (Tables)
 6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of shares issued granted options
    Six months ended June 30, 2022
    Number of options granted     Exercise
price
range		     Vesting
period		   Expiration
Employees     398,000       9.22     4 years   10 years
Directors     217,000       9.22     4 years   10 years

 

    Six months ended June 30, 2021
    Number of
options
granted		     Exercise
price
range		   Vesting
period
range		   Expiration
Employees     76,500     $12.78- 13.08   4 years   10 years

 
Schedule of fair value options granted
    Six months ended
June 30
    2022   2021
Value of ordinary share   $9.07-9.22   $11.9-$13.93
Dividend yield   0%   0%
Expected volatility   67.28%-67.95 %   65.36%-66.49 %
Risk-free interest rate   1.72%-3.03 %   0.64%-1.06 %
Expected term   6.11 years   6.11 years

 
Schedule of the number of options granted to employees under the option plan
    Number of
options		     Weighted
average
exercise
price		  
Options outstanding at the beginning of the period     1,220,694     $ 7.71  
Granted     615,000       9.22  
Exercised     (39,457 )     4.42  
Forfeited or expired     (10,938 )     10.49  
Options outstanding at the end of the year     1,785,299     $ 8.14  
Options exercisable at the end of the year     819,651     $ 6.5  

 
Schedule of the number of options granted to non- employees under the option plan
    Number of
options		     Weighted
average
exercise
price		  
Options outstanding at the beginning of the period     15,416     $ 16.04  
Granted    
-
      
-
  
Exercised    
-
      
-
  
Forfeited or expired    
-
      
-
  
Options outstanding at the end of the year     15,416     $ 16.04  
Options exercisable at the end of the year     9,141     $ 9.64  

 
Schedule of share-based compensation
    Six months ended
June 30		     Three months ended
June 30		  
    2022     2021     2022     2021  
    U.S. dollars in thousands     U.S. dollars in thousands  
Cost of revenue   $ 2     $ 42     $ 2     $ 18  
Research and development     374       378       173       219  
General, administrative, and marketing     647       542       400       246  
    $ 1,023     $ 962     $ 575     $ 483